Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy

NCT: NCT07822932 · NOT_YET_RECRUITING

NCT IDNCT07822932
StatusNOT_YET_RECRUITING
Start Date2026-11-01
Completion2028-09-30
SponsorUniversity of Miami (OTHER)
First posted
Last updated

Brief Summary

This study looks at a non-invasive ear stimulation treatment to better understand nerve pain in people living with HIV. The study aims to assess how the body and nervous system respond to this treatment, including changes in heart function and pain signals. The goal is to learn how future treatments for nerve pain may be improved.

Frequently Asked Questions

What is Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy?

Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy is a clinical trial registered under NCT07822932. Current status: NOT_YET_RECRUITING.

What is the status of NCT07822932?

The current status of NCT07822932 (Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy) is: NOT_YET_RECRUITING.

When did Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy start?

Auricular Vagus Nerve Stimulation Mechanisms for HIV-Associated Peripheral Neuropathy started on 2026-11-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.